Applications of All-Trans-Retinal in Industrial Manufacturing

As the original manufacturer of All-Trans-Retinal, we supply high-purity raw material for specialized industrial applications. Below, we detail the principal downstream industries using this compound, key compliance frameworks, and integration into manufacturing processes.

1. Pharmaceutical API Synthesis for Retinoid Drugs

Pharmaceutical companies source All-Trans-Retinal as an intermediate in the synthesis of certain retinoid-based active pharmaceutical ingredients, particularly for ophthalmic and dermatological drugs. Strict handling and storage minimize isomerization during production. GMP-compliant procedures dictate dissolution in anhydrous solvents for conversion or direct formulation, ensuring controlled impurity profiles. The material appears in specific finished dosages after extensive in-process quality checks and precise molar ratio calculations in multi-step organic synthesis routes.

Industry compliance standards

• ICH Q7 on Good Manufacturing Practice for APIs
• USP/NF and Ph. Eur. monographs for retinoids
• FDA cGMP (21 CFR Parts 210/211)
• EU EudraLex Vol 4, Part II for API manufacturing

Typical usage ratio

• 0.2–1.0 molar equivalents in stepwise API synthesis, precisely calculated per batch size; adjusted based on reaction stoichiometry and yield optimization

Downstream process integration

• Reacted during controlled condensation, reduction, or oxidation stages
• Dosed into reactor vessels following vacuum-drying and inertization
• Followed by in-situ conversion or crystallization with solvent exchange

Final product types

• Retinaldehyde-based ophthalmic solutions
• Topical dermatological creams for prescription
• Retinoid capsules and softgels

2. Ophthalmic Diagnostic Reagent Manufacturing

Diagnostic reagent producers utilize All-Trans-Retinal in the development of biochemical kits for retinal function testing and phototransduction assays. The compound functions as a key chromophore to regenerate photoactive proteins, which are essential in testing devices for research and clinical diagnostics. Formulation requires light-protected blending and rapid incorporation into buffer solutions to maintain functional activity, following sterile filtration and aliquoting protocols for single-use diagnostic units.

Industry compliance standards

• ISO 13485 (Quality Management for Medical Devices)
• IVDD/IVDR requirements for in vitro diagnostics in the EU
• FDA QSR (21 CFR Part 820)
• CLSI EP series quality guidelines

Typical usage ratio

• 1–10 micromoles per test kit, typically 0.01–0.1% (w/v) in reagent buffers; concentration varies by assay sensitivity/specification

Downstream process integration

• Added to stabilized buffer during final reagent mixing
• Aliquoted under amber lighting conditions into vials or microplates
• Subjected to sterile sealing and functional verification prior to packaging

Final product types

• Visual cycle functional assay kits
• Retinal-binding protein ELISA reagents
• Photoreceptor activity diagnostic strips

3. Nutritional Premix Production for Special Foods

Specialized nutrition and medical food manufacturers include All-Trans-Retinal in premix blends for controlled dietary supplementation, especially for research applications or regulated foodstuffs. The pure form is microencapsulated or solubilized for precise dosing and stability, with full traceability throughout blending and batching. Blending protocols follow strict allergen and oxidation controls to prevent degradation in multicomponent formulations, and batch records track each addition step for traceable supplement products.

Industry compliance standards

• Food Chemicals Codex (FCC) for ingredient purity
• EU Regulation (EC) No 1333/2008 (Food Additives)
• US FDA 21 CFR 172.515 (Generally Recognized as Safe, GRAS status, if applicable to retinal forms)
• GFSI benchmarked food safety programs (FSSC 22000/BRCGS)

Typical usage ratio

• 0.2–2 mg per serving in fortified premixes; final inclusion rate determined via analytical dosage design per food matrix and regulatory allowance in local markets

Downstream process integration

• Dispersed into carrier powder under nitrogen atmosphere
• Blended with other micronutrients using closed-system mixers
• Extracted/encapsulated for enhanced stability in the final premix

Final product types

• Medical enteral nutrition blends for clinical use
• Research-use-only dietary premixes for metabolic studies
• Vitamin A analog-supplemented control foods (where permitted)

4. Biotechnological Expression of Opsin Proteins

Biotechnology laboratories and production firms employ All-Trans-Retinal as a functional cofactor for expression and characterization of microbial and animal opsins in cell-based or cell-free systems. The compound is introduced during protein reconstitution or incorporated in vitro to support proper folding and function in optogenetics, protein engineering, and neural circuit research. Manufacturing protocols demand absolute light protection, use of oxygen-free solvents, and validated supply chain security.

Industry compliance standards

• ISO 9001 for quality management in R&D
• NIH and NSF guidelines for biotechnology materials handling
• Biosafety Level 1 or 2 (as appropriate for organism/cell type)
• OECD Principles of Good Laboratory Practice (GLP), for research-use reagents

Typical usage ratio

• 10–100 micromolar concentrations in culture or reaction medium; optimized per opsin protein expression system and downstream activity requirement

Downstream process integration

• Added to cell cultures during post-expression purification
• Reconstituted with purified opsin proteins in membrane vesicles
• Blended with assay buffers prior to functional testing or packaging for optogenetic research

Final product types

• Reconstituted channelrhodopsins for optogenetic modules
• Fluorescent reporter cell kits
• Synthetic retinal-binding protein standards

5. Cosmetic Ingredient Manufacturing for Anti-Aging Formulations

Regulated cosmetic manufacturers formulate All-Trans-Retinal in anti-aging serums and specialty night creams, leveraging its activity as a retinoid precursor. Integration involves microditribution in emulsions using light- and oxygen-exclusion protocols, combining with protective antioxidants and controlled-release carriers to stabilize the ingredient through the blending, emulsification, and filling processes. Compliance teams maintain project documentation for full traceability from raw material receipt through finished product release, covering all batch operations.

Industry compliance standards

• EU Cosmetics Regulation (EC) No 1223/2009
• US FDA Voluntary Cosmetic Registration Program (VCRP)
• ISO 22716 (Cosmetic GMP)
• China National Medical Products Administration (NMPA) filing for cosmetic ingredients

Typical usage ratio

• 0.05%–0.2% (w/w) in finished formulations; final concentration determined via safety evaluation and clinical test data

Downstream process integration

• Incorporated during late-phase emulsion blending under vacuum and light protection
• Dispersed with tocopherol or other antioxidants to prevent degradation
• Subjected to in-process stability and homogeneity testing prior to bulk filling

Final product types

• Night creams targeting fine lines and wrinkles
• High-performance facial serums
• Anti-aging spot treatment emulsions